5-Amino-1MQ: What the Research Shows About This NNMT Inhibitor

5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that blocks an enzyme called nicotinamide N-methyltransferase, or NNMT. It is sold as a research chemical and studied in laboratory models of obesity, insulin resistance, and cellular energy metabolism. There is no published human trial of 5-Amino-1MQ, and it is not approved by the FDA for use in people.

What Is 5-Amino-1MQ?

5-Amino-1MQ belongs to a family of quinolinium compounds. Its defining feature is a permanent positive charge, which makes it water-soluble and, in theory, limits how easily it crosses cell membranes.

Researchers treat it as a tool compound, meaning its job in the lab is to switch off NNMT so scientists can observe what happens next. It is not a vitamin, not a peptide, and not a prescription medication.

• Chemical class: quinolinium small molecule
• Primary target: nicotinamide N-methyltransferase (NNMT)
• Common research routes: oral gavage and injection in rodent studies
• Human data: none published
• Regulatory status in the US: not approved for human use

How 5-Amino-1MQ Is Thought to Work

NNMT consumes nicotinamide and a methyl group and converts them into 1-methylnicotinamide. When NNMT is overactive, it drains the pool of nicotinamide adenine dinucleotide (NAD+), a coenzyme that cells depend on for energy production and DNA repair.

Blocking NNMT is thought to preserve available NAD+ and change how fat cells and liver cells manage energy. That mechanism is why the compound is discussed in metabolic research rather than in recovery or performance circles.

Two caveats matter here. First, nearly all proposed benefits come from animal models, and mouse metabolism differs from human metabolism in significant ways. Second, inhibiting an enzyme broadly can affect tissues well beyond fat, including the liver and nervous system.

What the Research Actually Shows

Preclinical studies in diet-induced obese mice reported reduced body weight gain, smaller fat cells, and improved glucose tolerance after NNMT inhibition. Those effects appeared with both oral and injected administration in the animal models used.

Other work has linked elevated NNMT activity to insulin resistance, fatty liver disease, and several cancer types. That connection makes NNMT an appealing research target, but it does not prove that inhibiting the enzyme helps people.

Every metabolic claim about 5-Amino-1MQ rests on cell and animal data. No controlled human study has established benefit, dosing, or long-term safety.

5-Amino-1MQ vs Other Research Compounds

People researching metabolic compounds usually compare several at once. The table below shows how 5-Amino-1MQ lines up with four frequently discussed options.

Compound	Main mechanism	Typical research route	FDA-approved for humans?
5-Amino-1MQ	NNMT inhibition	Oral or injected in rodent studies	No
AOD-9604	hGH fragment 176-191; lipolysis research	Subcutaneous injection	No
Tesamorelin	GHRH analog that raises endogenous growth hormone	Subcutaneous injection	Yes, for HIV-associated lipodystrophy
MOTS-c	Mitochondrial-derived peptide; AMPK signaling	Subcutaneous injection	No
SLU-PP-332	ERR alpha, beta, and gamma agonist	Oral or injected in mice	No

The comparison 5-amino-1mq vs aod-9604 comes down mostly to mechanism: one targets an enzyme, while the other mimics a fragment of growth hormone. Neither is approved for human weight or metabolic use.

When a study design includes slu-pp-332 and 5-amino-1mq together, researchers are usually probing two different levers of energy metabolism rather than expecting an additive effect.

The debate over 5-amino-1mq vs tesamorelin is really a debate about evidence quality. Tesamorelin has completed human trials and holds an FDA indication, and 5-Amino-1MQ has not cleared that bar. Likewise, mots-c vs 5-amino-1mq contrasts a peptide that acts on mitochondrial signaling with a small molecule that acts on enzyme activity.

Dosage and Reconstitution: What the Evidence Allows

There is no established 5-Amino-1MQ dosage for humans. Rodent studies report amounts measured in milligrams per kilogram of body weight, and those figures cannot be translated directly into a human dose.

A frequent question among newcomers is: is amino h20 bac water an acceptable diluent for research compounds? Bacteriostatic water is the standard choice for peptide reconstitution because benzyl alcohol limits bacterial growth, while products marketed as "amino water" vary in composition and should be checked against the label.

Storage and handling matter as much as dilution. Research chemicals often ship as lyophilized powder and should be kept cool, dry, and protected from light, then handled with sterile technique to avoid contamination.

Safety, Sourcing, and Legal Status

5-Amino-1MQ is not FDA-approved for human use in the United States. It is sold for laboratory research only, which means purity, sterility, and actual identity are the buyer's responsibility to verify.

• Request a third-party certificate of analysis (COA) with a matching batch number.
• Treat unverified sellers and unusually cheap listings as a red flag.
• Do not assume a compound sold online is legal to possess or use in every state.
• Talk with a licensed healthcare professional before considering any unapproved substance.

Human side effects are simply unknown, because the studies needed to identify them have not been run. Anyone who is pregnant, has a medical condition, or takes prescription medication faces additional unknowns.

Bottom Line

5-Amino-1MQ is a legitimate tool in laboratory metabolic research and an unproven product in the consumer market. The distance between promising mouse data and a real human outcome is wide, and it closes only with controlled trials that have not yet been conducted.

COMMON QUESTIONS

Frequently Asked Questions

What is 5-Amino-1MQ used for?

In laboratories, 5-Amino-1MQ is used as a tool compound to inhibit the enzyme NNMT so researchers can study energy metabolism, fat cell biology, and insulin sensitivity. Those experiments have been limited to cell cultures and rodent models. It is sold as a research chemical and is not approved for human use.

Is 5-Amino-1MQ safe for humans?

No human safety data exists for 5-Amino-1MQ because no controlled human trials have been published. The FDA has not approved it for any human indication, and its long-term effects, interactions, and side effect profile are unknown. Anyone considering an unapproved research chemical should speak with a licensed healthcare professional first.

Is there a standard 5-Amino-1MQ dosage?

There is no established human dosage for 5-Amino-1MQ. Rodent studies use amounts expressed in milligrams per kilogram of body weight, and those numbers do not translate reliably into human dosing. Self-dosing with a compound that has no human safety data carries significant and largely unknown risk.